22nd Century Group Inc. (NYSE-A: XXII)

22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology which allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding.